GLP–1s: A Healthcare Revolution?

One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.

GLP-1s: A Healthcare Revolution? IpsosThe age of GLP-1s is upon us, with the potential to transform healthcare as we know it. What began as a treatment for type 2 diabetes has expanded to reinvent obesity management – and the promise of this drug class extends far beyond these two diseases for which it is currently approved. 

In this paper, we highlight the impact of GLP-1s to date, and discuss ongoing research suggesting their game-changing potential in combating some of the world's most prevalent and devastating conditions – both within and outside the metabolic arena. We also consider the implications for future healthcare delivery, cost reduction, and the pharmaceutical industry.

Ultimately, we look into a future where millions of lives could potentially be transformed, healthcare burdens dramatically reduced, and new frontiers of treatment unlocked.

The future of medicine is here, and it is led by the GLP-1s.

Download the full paper

The author(s)

More insights about Health

Related news

  • The Human Advantage Conference 2026: Highlights

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.